CyberKnife® Robotic Radiosurgery Offers Equal Success Rates, Shorter Treatment Times Compared to Intensity Modulated Radiation Therapy (IMRT)

Crozer-Keystone Health System recently issued a press release about a new study that has found that the CyberKnife Robotic Radiosurgery System is able to offer prostate cancer patients success rates equal to intensity modulated radiation therapy (IMRT), with shorter treatment duration and lower total cost. 

A team of Crozer-Keystone oncology specialists based out of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System, conducted the five-year study, and their findings were published in the February edition of the Journal of Radiation Oncology. 

The paper, titled “Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer,” was authored by Dr. Lanciano and her research colleagues, Caspian Oliai, Matthew Bernetich, Luther Brady, Jun Yang, Alexandra Hanlon, John Lamond, Steven Arrigo, Michael Good, Michael Mooreville and Bruce Garber. 

To read the press release in its entirety, please click here.